ArticleACS medicinal chemistry letters2021

Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1.

Andrew P Degnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.